MoneyWorks4Me

Aurobindo Pharma informs about press release

26 Apr 2025 Evaluate
Aurobindo Pharma has informed that it enclosed a copy of the Press Release that is being issued by CuraTeQ Biologics s.r.o, a wholly owned stepdown subsidiary of the Company in connection with the receipt of Positive Opinion from CHMP for Dazublys®, a Trastuzumab Biosimilar.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..